Menu
There are more than 33,300 Australians living with MS
$4 million invested into a new clinical trial to look into neuroprotection and myelin repair in progressive MS
Established in 2008 to coordinate post-mortem tissue use from people living with MS for research
62% of people with MS use a disease modifying therapy (DMT), a decrease of 2% since 2017
